Opening book details…
About this Medicine article
6004 ORAL Oblimersen plus fludarabine/cyclophosphamide (FC) significantly increases complete remission and overall survival in non-refractory patients (Pts) with relapsed chronic lymphocytic leukemia (CLL): results from a prospective randomized phase 3 trial by Novick, S.; O'Brien, S.; Moore, J.; Boyd, T.; Ding, L.; Rai, K. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Novick, S.; O'Brien, S.; Moore, J.; Boyd, T.; Ding, L.; Rai, K.
- Publisher
- Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 1359-6349)
- Published
- 2007
- Language
- EN
- Field
- Medicine (Health Sciences)
More by Novick, S.; O'Brien, S.; Moore, J.; Boyd, T.; Ding, L.; Rai, K.
Browse all works by Novick, S.; O'Brien, S.; Moore, J.; Boyd, T.; Ding, L.; Rai, K.